Welcome to Nofinity

The current crypto bear market in 2026 is fundamentally different from 2022. Companies that depended on cheap money are dying, not because of fraud or scandals. This is a normal process of rationalization and market bottoming. Main causes of death for failed companies:

• BitMEX: Shuts down after 11 years, inventor of the perpetual swap. Daily volume fell to under $400k (0.01% of the market), squeezed by Binance and Hyperliquid.
• Storage: Decentralized storage network; parent company files Chapter 11 due to debt from acquiring GPU firm Valdi ($1-10M).
• Regulatory casualties: Ascend EX (due to MiCA), EXMO (UK sanctions) – insolvency and frozen funds.
• Runway problems: Projects like Odos, Dango, Leap Wallet, Entropy – simply ran out of money or gave up after exploits.

Difference from 2022:

• 2022: Fraud and contagion (FTX, Celsius) – missing customer funds, systemic crises.
• 2026: Rationalization – independent, unprofitable companies close orderly. Withdrawals still work. No major scandals.

Second wave of selling: Digital Asset Treasury Companies (DATs):

• Companies like Strategy (formerly MicroStrategy) had to sell Bitcoin for the first time to pay preferred dividends. The "Never Sell" doctrine is broken.
• Over $62B in market cap of such firms evaporated in June 2026.
• These are forced sales from buyers at the top – a classic bottoming signal.

Where is capital flowing? – The AI Boom:

• Crypto miners are pivoting to AI infrastructure providers. They sell Bitcoin to fund data centers for AI (e.g., Terawolf, Hut 8).
• Cost per megawatt for AI is 10-20x higher than for mining. This is capital rotation, not panic.
• Forecasts: AI could make up 70-80% of major miner revenue by end of 2026.

Market indicators for a bottom:

• Long-term holders (LTHs) realize 43% of all losses – a sign of capitulation.
• Exchange balances at 7-year low (2.21M BTC), coins moving to cold storage.
• Perpetual funding neutral – leverage is mostly purged.
• ETF outflows in June ($4.5B), but first inflows in July suggest exhausted sellers.

Caution:

• The drawdown of 51% (from ATH at $126k) is still shallow compared to previous bear markets (78-84%).
• A final flush could still be ahead, but structural demand from ETFs and Treasury buyers cushions the fall.

Conclusion:

• The death of many crypto firms and forced sales from treasury companies are part of a normal bottom formation process.
• Historically, buying at the bottom (2018, 2022) yielded massive returns (700-2000% over 24-36 months).

🔥 Bond Shock: Escalation in the Bond Market

US 10-year Treasury yields have surged above 5% – the fastest pace since the 1980s. This creates a stress test for equities.

🐻 The Bear Case: “Washington, you’ve got a problem”

• Oil & Diesel: Rising diesel prices fuel inflation; Trump threatens an export stop that could raise fuel costs in Germany by up to 25%.
• Earnings expectations downgraded: For the first time in months, more analysts cut earnings forecasts than raise them.
• Oracle crisis: AI mega data center “Jupiter” invokes force majeure – financial strain threatens the sector.
• OECD risk scenario: Warns of potential 15% stock market decline by 2027.
• Weak market breadth: 60% of S&P 500 stocks trade below their 100-day moving average.

🐂 The Bull Case: “Things are better than sentiment”

• US economy booming: GDP Nowcast above 5%, PMIs at multi-year highs, 47% of companies plan to hire.
• Inflation expectations stable: Yield rise reflects strong growth, not runaway inflation.
• Yields in context: At 5.1% vs. nominal growth >5%, the level is reasonable, not alarming.
• AI investment intact: Nvidia B200 chip lease rates +30%, hyperscaler cloud revenues rising, South Korean exports strong.
• Bears outnumber bulls: 48% bearish sentiment – a contrarian signal that often precedes rallies.

📉 Winners & Losers of the Week

Winners	Losers
Viking Therapeutics (+36%) – strong obesity drug data	Oracle – force majeure for AI project, financing fears
Meta – new AI agent well received	Novo Nordisk – Viking competition
Intel, AMD – AI tailwinds	McDonald’s – costly remodeling, margin pressure
Shopify – AI shopping fantasy	Vonovia – rising rates + Berlin election
Nebius – Bank of America upgrade	Volkswagen – profit warning, billion writedown

💡 Investment Ideas & Outlook

• Weekly World Income ETF (HANetf): Weekly dividends via covered call strategy, 0.5% expense ratio, target ~8% p.a. (not guaranteed). Holds big tech, >81% US exposure.
• Memory stocks (Micron, SK Hynix) at historically low valuations – potential rebound.
• Low volatility & Dividend Aristocrats more resilient during yield spikes.
• Latin America: Brazil (93% of global niobium – key for AI/power grids), Argentina (Milei reforms). Political upside if Flávio Bolsonaro wins.

⚠️ Conclusion: A Trap for Pessimists?

The rising yields primarily reflect strong growth, not an inflation explosion. Short-term volatility is possible, but historically rapid yield increases have had negligible impact on 1-year stock returns. Overwhelming bearish sentiment may actually be a contrarian buy signal.

In this deep technical analysis, the Into the Cryptoverse host focuses on Bitcoin's upcoming weekly close and its significance for Q4. He emphasizes a reactive approach over predictions and admits being wrong about the recent rally above the May high.

Why the Weekly Close Matters

• A close below the May high (around 83K) would be strongly bearish, suggesting a massive fakeout before typical Q4 weakness.
• A close above the May high would confirm the bull market and further boost bullish sentiment.
• The speaker warns: "Don't predict it. React."

Historical Parallel: Silver in 2012

• Bitcoin's current price action mirrors silver's 2012 chart: a ~6% spike above the prior high, followed by a retreat.
• Back then, a failed expectation of QE caused the debasement trade to unwind – a similar dynamic could play out for Bitcoin.

Macro Headwinds

• Rising bond yields (30-year at 5.5%, heading toward 6%) and a strengthening dollar are typically negative for risk assets.
• If Bitcoin shrugs off these pressures and holds above the May high, the bearish case weakens further.
• A close below the May high, however, would pave the way for Q4 weakness, with altcoins being the most vulnerable.

React, Don’t Predict

• Two consecutive weekly closes are needed: the first above the May high has occurred; the confirmation week is still ongoing.
• Historical data from September rate hikes in midterm years shows that weakness often appears 30–80 days later, with an average 29% drawdown.
• The speaker remains humble: "I was wrong about the May high, and the market doesn't have to make sense."

Bottom line: Bitcoin's weekly close is one of the most consequential indicators of the year. A rejection below the May high would strongly suggest a Q4 correction, while acceptance above would reinforce the bull market narrative.

Introduction

• Aaron Bernett, a space expert and one of the most re-posted analysts by Elon Musk, joins the show.
• Topic: “Trillions in Space” – trillion-dollar markets in orbit, driven by SpaceX, Starship, and AI infrastructure.
• Special focus: EWS (Elon Web Services) – the AI factory in space is becoming a major part of the SpaceX story.

EWS & AI Data Centers in Space

• EWS describes SpaceX's AI services; building data centers in orbit is seen as a real future model.
• Terrestrial challenges (permits, energy) make space attractive – solar power already supplies 11,000 satellites.
• To the skeptics saying “space data centers are impossible”: It's an engineering challenge, not a physics limit.
• Critical cost factor: next-generation radiators for heat dissipation in zero gravity.

Starship & Economics

• Reusability is not a question of if, but of scale: from around $100/kg toward $10/kg through mass production.
• SpaceX has a historic lead in launches, satellites, and successful payloads – the gap to competitors is enormous.
• The “space premium” logic: The more real orbital execution, the bigger the valuation gap.
• Competitors (e.g., Starlink alternatives) struggle to keep up with the pace of evolution.

Models & Valuation

• Aaron deliberately uses crude pricing models and Monte Carlo simulations.
• Result: $527 base target = 3.61× from current levels by 2028; the outlook for 2030 remains incomplete in the transcript, but the models show long right tails.
• The Starlink side is more bullish; demand for AI compute remains strong.
• Competitive risk: open-source models and cheaper AI could attack the “moats” of players like Anthropic/OpenAI.

Additional Insights

• MCP/plugins generate 15× more usage per user than classic research.
• Google is sending a TPU chip to space on a Falcon rocket – a strong signal.
• Future vision: AI agents, Optimus robots, and far higher token counts than today's LLMs (only ~100 tokens).
• Space debris is finally being taken seriously – the marine radar analogy highlights collision risks.

Introduction: The Controversial Porsche 911 GT3 SC

This is the latest variant of the 911 GT3 – the SC model. It marries the chassis and drivetrain of the GT3 with the body of a 911 Cabriolet. The author is initially skeptical: For him, a GT3 should be about precision, feedback, and driving dynamics – a convertible seems like a betrayal.

Technical Details and Lightweight Construction

• Body: Carbon fiber hood, front wings, and doors (from the ST).
• Weight: 1,497 kg (about 70 kg more than the coupe).
• Roof: Fully electric, opening in 12 seconds at up to 30 mph (48 km/h).
• Suspension: Carbon fiber anti-roll bars, drop links, shear panel – all carbon.
• Transmission: Only 6-speed manual (dual-mass flywheel instead of single-mass).
• Engine: 503 hp, 9,000 rpm, naturally aspirated – still fantastic.
• Price: Approximately £200,500 (about £35,000 more than the coupe).

Interior and Features

• Seats: Foldable bucket seats, no rear seats.
• Headrests: Not removable (unlike the coupe).
• Door cards: Lightweight from the ST.
• Drive modes: Normal, Sport, Track – including damper adjustment.
• Wind deflector: Electric.

Driving Impressions on Track

The author drives the GT3 SC at Portimão racetrack – deliberately provocative, as the convertible is actually intended for country roads.

• Engine and Gearbox: Excellent – the naturally aspirated engine revs eagerly to 9,000 rpm, the manual gearbox with flat-shift is thrilling.
• Handling: Precise, balanced, but not quite as sharp as the coupe. Slightly more compliance and a hint of sluggishness.
• Body stiffness: The missing roof structure is noticeable – the convertible feels less direct and has slightly softer suspension.
• Verdict: Despite all criticism, the SC is a fantastic car – it brings you closer to one of the world's great engines. Not ideal for purists, but understandable.

Verdict: Worst GT3 Ever?

Maybe – but even then it would be better than 99% of other sports cars. The author admits he would judge owners harshly at first, but deep down he understands. Bottom line: A GT3 for enthusiasts who love open-top driving.

Overview

Dr. Irina Conboy (formerly UC Berkeley, now CSO at Generation Lab) discusses her latest study on selective targeting of cancer and senescent cells and the future of systemic rejuvenation.

Study Results: +41% Lifespan?

• The triple combination (DMA) of dichloroacetate (DCA), metformin, and ABT263 (navitoclax) was tested in 18–20-month-old mice – equivalent to a 65–70-year-old human.
• From treatment start, mice lived ~41% longer; relative to total lifespan, the extension was ~10–12%.
• Importantly, the main goal was not lifespan extension but eliminating cancer and senescent cells together without harming healthy cells.
• Mice showed improved treadmill performance and no increase in frailty – despite a chemo-like intervention.

Mechanism: A Shared Vulnerability

• Cancer and senescent cells have damaged mitochondria and heavily depend on glycolysis.
• DCA forces cells to push pyruvate into mitochondria and use oxidative phosphorylation.
• Metformin inhibits mitochondrial electron transport (complex I), worsening the energy crisis.
• ABT263 blocks BCL survival proteins, allowing cytochrome C release and triggering apoptosis.
• Crucially, healthy cells have enough functional mitochondria and survive; diseased cells die selectively.

Safety and Key Features

• ABT263 was used at only one-tenth of the usual dose to avoid thrombocytopenia (low platelets).
• In vitro tests on various human cells showed: cancer and senescent cells were eliminated, while healthy liver and neuronal cells remained largely unaffected.
• The authors view DMA not as a classic senolytic or chemotherapeutic, but as a dual-capacity therapy against both pathogenic cell types.

Outlook: Generation Lab and FDA

• Generation Lab is developing an injectable substitute for therapeutic plasma exchange (TPE) that antagonizes age- and disease-elevated blood proteins and promotes tissue repair.
• The drug "One Generation" consists of two FDA-approved components and is being prepared for clinical trials.
• A potential indication is prevention and treatment of cardiovascular disease.
• Dr. Conboy advises against biohacking with the combination until safety and dosing are validated in clinical trials.

Bull Market Confirmed

• Experts like Ben Cowan and Michael Nato declare the bull market official – based on the Golden Cross (50-day MA crossing above 200-day MA), on-chain metrics (coins shifting from weak to strong hands), and leverage reset.
• Bitcoin has reclaimed the 200-week moving average and is at an 8-month high. However, a drop below ~$65k would break the early-bull thesis.

Who’s Leading This Cycle?

• Bitcoin remains large ($1.7T), but flows are increasingly directed to smaller coins with actual revenue:
  • Zcash (+10-year high) – private money, competing with Bitcoin as a store of value.
  • Near, Arbitrum, Onondo, Uniswap, Jupiter – all have real earnings (fees, buybacks).
• The blue chips (BTC, ETH) struggle to attract new buyers due to their size and lack of clear cash flows.

Macro & Bonds

• U.S. Treasuries (10-year at 5.15%, 30-year at 5.44%) – highest yields in over 20 years.
• Howard Marks (bond expert) cites three reasons: high inflation, lack of fiscal discipline, and AI capital demand ($5T). He recommends cryptocurrencies as a hedge against debasement.
• Rising yields barely affect Bitcoin – the correlation is low (0.18 inverse) because crypto is driven by cycles and herd mentality.

Altcoin Highlights & Controversies

• Kalshi (prediction market) accused of wash trading – nearly 1 million identical trades of $5,500. The CFTC is not investigating yet, but the story isn’t over.
• Vitalik endorses Truo – an “ethical” prediction market on Ethereum L1. Truo token briefly jumped 10x after his tweet (market cap now ~$10M).
• Variational – new derivatives aggregator, airdrop of 32% supply, 100% revenue goes to buyback & burn.
• BlackRock partners with Onondo on intelligent portfolios (tokenized RWAs, managed by BlackRock). Also publishes a report on AI and digital money.
• Binance takes a $100M stake in Circle (USDC) with a 5-year partnership.
• Coinbase opens IPO allocations to U.S. retail, expanding into stock trading.

Conclusion

The bull market is here, but leadership is shifting from Bitcoin to revenue-bearing altcoins. Meanwhile, rising bond yields pressure macro – yet crypto seems immune as long as its own cycles dominate.